SCHEMBL6980939

SCHEMBL6980939

Nc1nc(N)nc(-c2ccc(-c3ccccc3)o2)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.61
ADORA1 P30542 5/20 0.61
ADORA3 P0DMS8 3/20 0.61
ADORA2B P29275 2/20 0.61
POLB P06746 1/20 0.61
NQO2 P16083 2/20 0.49
CYP2E1 P05181 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2A6 P11509 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2B6 P20813 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
ALOX15 P16050 2/20 0.42
TSHR P16473 1/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoguanamine SCHEMBL28634836 0.77 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2BPOLB
Benzoguanamine SCHEMBL27898 0.77 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2BPOLB
Benzoguanamine SCHEMBL917182 0.77 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL76097 0.76 CYP2E1 (0.58) POLBNQO2CYP2E1CYP3A4CYP2D6
Benzoguanamine SCHEMBL11620040 0.74 ADORA2A (0.95) ADORA2AADORA1ADORA3ADORA2BPOLB
Benzoguanamine SCHEMBL8613754 0.74 ADORA2A (0.95) ADORA2AADORA1ADORA3ADORA2BPOLB
Benzoguanamine SCHEMBL29131394 0.74 ADORA2A (0.95) ADORA2AADORA1ADORA3ADORA2BPOLB
Biphenyl SCHEMBL183386 0.73 ADORA2A (0.75) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL12230560 0.73 HSD17B10 (0.64) NQO2CYP2E1CYP3A4CYP2D6CYP2A6
SCHEMBL6977514 0.73 ADORA1 (0.91) ADORA2AADORA1ADORA3ADORA2BPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US claimed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed